James Loerop
Net Worth
Last updated:
What is James Loerop net worth?
The estimated net worth of Mr. James Loerop is at least $2,892,184 as of 8 Jul 2021. He owns shares worth $15,084 as insider and has received compensation worth at least $2,877,100 in Anika Therapeutics, Inc..
What is the salary of James Loerop?
Mr. James Loerop salary is $575,420 per year as Executive Vice President of Bus. Devel. & Strategic Planning in Anika Therapeutics, Inc..
How old is James Loerop?
Mr. James Loerop is 61 years old, born in 1964.
What stocks does James Loerop currently own?
As insider, Mr. James Loerop owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | Executive Vice President of Bus. Devel. & Strategic Planning | 1,756 | $8.59 | $15,084 |
What does Anika Therapeutics, Inc. do?
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products. The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.
James Loerop insider trading
Anika Therapeutics, Inc.
Mr. James Loerop has made only one insider trade between 2020-2021, according to the Form 4 filled with the SEC.
As of 8 Jul 2021 he still owns at least 1,756 units of ANIK stock.
Anika Therapeutics key executives
Anika Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Cheryl Renee Blanchard Ph.D. (61) Pres, Chief Executive Officer & Director
- Mr. David Colleran (53) Executive Vice President, Gen. Counsel & Corporation Sec.
- Mr. James Loerop (61) Executive Vice President of Bus. Devel. & Strategic Planning
- Mr. Michael L. Levitz (51) Executive Vice President, Chief Financial Officer & Treasurer
- Mr. Thomas M. Finnerty (67) Executive Vice President of HR